Moffitt logo

Clinical Trials Search

Clinical Trial 21248

Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#: NCT04778397

Phase: Phase III
Principal Investigator: Sallman, David

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician s Choice of Venetoclax in Combination with Azacitidine or Intensive Chemotherapy in Previously Untreated Patients with TP53 Mutant Acute Myeloid Leukemia

Summary

Objective

Treatments

Therapies

Chemotherapy (NOS); Therapy (NOS)

Medications

Cytarabine (Cytosine Arabinoside); Daunomycin (daunorubicin); Diphenhydramine (); GDC-0199 (Venetoclax); Idarubicin (); Magrolimab (); Venetoclax (); Zevados (Idarubicin); acetaminophen (); azacitidine (5-azacitidine); daunorubicin ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.